Published in TB and Outbreaks Week, October 17th, 2000
A study conducted by researchers in Spain shows that prophylactic isoniazid (INH) therapy, when administered to liver transplant patients with a potential risk for tuberculosis, can cause severe liver toxicity.
N. Benito and colleagues issued a report of their study in Toronto, Ontario, Canada, at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Although the tuberculin skin test (TST) is meant to detect people at risk for developing Mycobacterium tuberculosis infections, Benito et al....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week